UNIGE document Scientific Article
previous document  unige:19999  next document
add to browser collection
Title

Potent inhibition of HIV-1 by TRIM5-cyclophilin fusion proteins engineered from human components

Authors
Ziegler, Patrick
Strambio-De-Castillia, Caterina
Grutter, Christian
Martinetti, Gladys
Mazzucchelli, Luca
Grutter, Markus
show hidden authors show all authors [1 - 10]
Published in Journal of Clinical Investigation. 2009, vol. 119, no. 10, p. 3035-3047
Abstract New World monkeys of the genus Aotus synthesize a fusion protein (AoT5Cyp) containing tripartite motif-containing 5 (TRIM5) and cyclophilin A (CypA) that potently blocks HIV-1 infection. We attempted to generate a human HIV-1 inhibitor modeled after AoT5Cyp, by fusing human CypA to human TRIM5 (hT5Cyp). Of 13 constructs, 3 showed substantial HIV-1-inhibitory activity when expressed in human cell lines. This activity required capsid binding by CypA and correlated with CypA linkage to the TRIM5a capsid-specificity determinant and the ability to form cytoplasmic bodies. CXCR4- and CCR5-tropic HIV-1 clones and primary isolates were inhibited from infecting multiple human macrophage and T cell lines and primary cells by hT5Cyp, as were HIV-2ROD, SIVAGMtan, FIVPET, and a circulating HIV-1 isolate previously reported to be AoT5Cyp resistant. The anti-HIV-1 activity of hT5Cyp was surprisingly more effective than that of the well-characterized rhesus TRIM5alpha, especially in T cells. hT5Cyp also blocked HIV-1 infection of primary CD4+ T cells and macrophages and conferred a survival advantage to these cells without disrupting their function. Extensive attempts to elicit HIV-1 resistance to hT5Cyp were unsuccessful. Finally, Rag2-/-gammac-/- mice were engrafted with human CD4+ T cells that had been transduced by optimized lentiviral vectors bearing hT5Cyp. Upon challenge with HIV-1, these mice showed decreased viremia and productive infection in lymphoid organs and preserved numbers of human CD4+ T cells. We conclude that hT5Cyp is an extraordinarily robust inhibitor of HIV-1 replication and a promising anti-HIV-1 gene therapy candidate.
Keywords Adoptive TransferAmino Acid SequenceAnimalsAnti-HIV Agents/*metabolismAotidaeCD4-Positive T-Lymphocytes/cytology/immunologyCarrier Proteins/genetics/*metabolismCell LineCyclophilin A/genetics/*metabolismDNA-Binding Proteins/genetics/metabolismHIV-1/*metabolismHumansMiceMice, KnockoutModels, MolecularMolecular Sequence DataProtein ConformationProtein EngineeringRecombinant Fusion Proteins/genetics/*metabolism
Identifiers
PMID: 19741300
Full text
Article - document accessible for UNIGE members only Limited access to UNIGE
Structures
Research group Réplication virale, pathogénèse et immunité (848)
Citation
(ISO format)
NEAGU, Martha Raluca et al. Potent inhibition of HIV-1 by TRIM5-cyclophilin fusion proteins engineered from human components. In: Journal of Clinical Investigation, 2009, vol. 119, n° 10, p. 3035-3047. doi: 10.1172/JCI39354 https://archive-ouverte.unige.ch/unige:19999

382 hits

0 download

Update

Deposited on : 2012-04-23

Export document
Format :
Citation style :